vimarsana.com

Page 3 - ஐரோப்பிய நிறுவனம் க்கு கண்டுபிடிப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A new consortium of the EU Innovative Medicines Initiative (IMI) will establish the biggest database of pathology images to accelerate the development of artificial intelligence in medicine

(1) NIJMEGEN, Netherlands, Jan. 28, 2021 /PRNewswire/ To take AI development in pathology to the next level, a European consortium combining leading European research centres, hospitals as well as major pharmaceutical industries, is going to develop a repository for the sharing of pathology data. The 6-year, €70 million project called BIGPICTURE, will herald a new era in pathology. Background: Sectra contributes to accelerate AI innovation for diagnostics in digital pathology Sectra engages in the new EU Innovative Medicines Initiative project BIGPICTURE to construct a large-scale database of pathology images. Sectra s contributions will help accelerate the development of improved diagnostic methods based on artificial intelligence, supporting an effective interplay between healthcare and academic research. The Sectra efforts include a close collaboration with the BIGPICTURE partners Center for Medical Image Science and Visualization (CMIV) at Linköping University and Regio

A new consortium of the EU Innovative Medicines Initiative (IMI)

 E-Mail A new consortium of the EU Innovative Medicines Initiative (IMI) aims to establish the biggest database of pathology images to accelerate the development of artificial intelligence in medicine. To take AI development in pathology to the next level, a European consortium combining leading European research centres, hospitals as well as major pharmaceutical industries, is going to develop a repository for the sharing of pathology data. The 6-year, €70 million project called BIGPICTURE, will herald a new era in pathology. Pathology is the cornerstone of the workup of many diseases such as cancer, autoimmune diseases, of the follow up after transplantation and is also critical for the evaluation of the safety of drugs. It s based on the examination of tissue samples (slides) under the microscope. However, despite its pivotal role, it still relies heavily on the qualitative interpretation by a qualified pathologist.

Let the party begin: EU Commission plans symbolic launch for Horizon Europe | Science

26 Jan 2021   |   News Let the party begin: EU Commission plans ‘symbolic launch’ for Horizon Europe An event on 2 February will mark the end of the lengthy negotiations and preparations for the next research programme. But with significant elements still to be settled, the funds won’t be flowing for a while The European Commission is about to uncork the champagne to mark the start of Horizon Europe, but significant parts of the research programme are still being negotiated, as stakeholders scramble for last minute changes. The Commission and the Portuguese presidency of the EU Council will host the launch event for Horizon Europe on 2 February, with terms for public private partnerships, the legal framework under which the European Institute for Innovation and Technology (EIT) will operate, and the scope of the research missions, yet to be agreed.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.